gC399tr an inhibitor of autoimmunity
gC399tr 自身免疫抑制剂
基本信息
- 批准号:7779385
- 负责人:
- 金额:$ 11.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:Angiogenesis InhibitorsAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAutoimmunityBindingBinding SitesBiochemistryBiologyBlood VesselsC-terminalC57BL/6 MouseCell Surface ReceptorsCell physiologyCellsChronicClinicalDermatologyDevelopmentDiagnosisDiseaseDisseminated Intravascular CoagulationDockingDoctor of MedicineEncephalomyelitisEndothelial CellsExperimental Autoimmune EncephalomyelitisFibrinogenGoalsHumanITGAM geneImmune responseImmune systemImmunologistImmunologyIn VitroInflammationInflammatoryIntegrin BindingIntegrinsLearningMeasuresMediatingMentorsMicrogliaMolecular BiologyMusPhysiciansPhysiological ProcessesPlayPreventionPropertyResearchRoleScientistSignal TransductionSurfaceT-LymphocyteTestingTherapeutic AgentsTissuesTrainingTubeWound Healingangiogenesisanticancer researchautoantibody inhibitorbasefibrinopeptides gammain vivointerestmacrophagemigrationmutantnew growthpreventsimulationtumortumor growth
项目摘要
DESCRIPTION (provided by applicant): Emanual Maverakis, M.D. is a cellular immunologist with clinical training in dermatology. One objective of this proposal is to provide him with a period of mentored training in molecular biology and biochemistry under the guidance of Dr. Yoshikazu Takada, an expert biochemist known best for identifying and characterizing several of the ¿1 integrins. Dr. Maverakis' ultimate goal is to develop into an independent physician scientist. To help with this transition, he will learn molecular biology and biochemistry while characterizing the ability of a fragment of fibrinogen, ?C399tr, to inhibit autoimmunity. The specific hypothesis is that ?C399tr will be able to inhibit autoimmunity through its ability to bind integrins. That hypothesis is based on the following observations. First, a well-characterized MAC-1 binding site exists within ?C399tr. (MAC-1 is an integrin on the surface of macrophages and microglia). Second, docking simulation studies have identified integrins aV¿3 and a4¿1 as potential targets for ?C399tr. Third, antibodies directed against a4¿1 integrin are known to prevent autoimmunity in animals and humans.
The following are the proposal's specific aims.
Specific Aim 1: Identify the integrins and cells bound by ?C399tr.
Specific Aim 2: Identify ?C399tr's effect on the immune response.
Specific Aim 3: Determine if ?C399tr is able to inhibit autoimmunity.
描述(由申请人提供):Emanual Maverakis,M.D.是一位细胞免疫学家,接受过皮肤病学的临床培训。该提案的一个目标是在高田义一博士的指导下为他提供一段时间的分子生物学和生物化学方面的指导培训,高田义一博士是一位以识别和表征多种1整合素而闻名的生物化学专家。Maverakis博士的最终目标是发展成为一名独立的医生科学家。为了帮助这种转变,他将学习分子生物学和生物化学,同时表征纤维蛋白原片段的能力,?C399 tr,抑制自身免疫。具体的假设是什么?C399 tr将能够通过其结合整联蛋白的能力来抑制自身免疫。这一假设基于以下观察。首先,一个良好的特点MAC-1结合位点内存在?C399tr.(MAC-1是巨噬细胞和小胶质细胞表面的整合素)。第二,对接模拟研究已经确定整合素aV <$3和a4 <$1作为潜在的目标?C399tr.第三,已知针对a4 ² 1整联蛋白的抗体可以预防动物和人类的自身免疫。
以下是该提案的具体目标。
具体目标1:确定整合素和细胞结合?C399tr.
具体目标2:识别?C399 tr对免疫反应的影响。
具体目标3:确定是否?C399 tr能够抑制自身免疫。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A T cell-binding fragment of fibrinogen can prevent autoimmunity.
纤维蛋白原的 T 细胞结合片段可以预防自身免疫。
- DOI:10.1016/j.jaut.2009.11.017
- 发表时间:2010
- 期刊:
- 影响因子:12.8
- 作者:Takada,Yoshikazu;Ono,Yoko;Saegusa,Jun;Sagusa,Jun;Mitsiades,Constantine;Mitsiades,Nicholas;Tsai,Jean;He,Yong;Maningding,Ernest;Coleman,Annie;Ramirez-Maverakis,Dalila;Rodrigues,Raphael;Rodriquez,Raphael;Takada,Yoko;Maverakis,Ema
- 通讯作者:Maverakis,Ema
Light, including ultraviolet.
- DOI:10.1016/j.jaut.2009.11.011
- 发表时间:2010-05
- 期刊:
- 影响因子:12.8
- 作者:Maverakis E;Miyamura Y;Bowen MP;Correa G;Ono Y;Goodarzi H
- 通讯作者:Goodarzi H
Presentation of a determinant by MHC class II can be prevented through competitive capture by a flanking determinant on a multideterminant peptide.
通过多决定簇肽上的侧翼决定簇的竞争性捕获,可以防止 II 类 MHC 呈递决定簇。
- DOI:10.1016/j.jaut.2008.02.004
- 发表时间:2008
- 期刊:
- 影响因子:12.8
- 作者:Maverakis,Emanual;Beech,JonathanT;Schneider,Susanne;Sercarz,EliE
- 通讯作者:Sercarz,EliE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emanual M. Maverakis其他文献
Emanual M. Maverakis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emanual M. Maverakis', 18)}}的其他基金
Stratedigm S100EON high-parameter flow cytometer to support multi-institutional research programs
Stratigm S100EON 高参数流式细胞仪支持多机构研究项目
- 批准号:
10431674 - 财政年份:2022
- 资助金额:
$ 11.9万 - 项目类别:
Mentoring Translational Scientists in Clinical Trial Immune Monitoring
指导转化科学家进行临床试验免疫监测
- 批准号:
10359792 - 财政年份:2021
- 资助金额:
$ 11.9万 - 项目类别:
Mentoring Translational Scientists in Clinical Trial Immune Monitoring
指导转化科学家进行临床试验免疫监测
- 批准号:
10670051 - 财政年份:2021
- 资助金额:
$ 11.9万 - 项目类别:
Investigation and Development of New Therapeutic Avenues for Scleroderma
硬皮病新治疗途径的研究和开发
- 批准号:
8792820 - 财政年份:2011
- 资助金额:
$ 11.9万 - 项目类别:
Investigation and Development of New Therapeutic Avenues for Scleroderma
硬皮病新治疗途径的研究和开发
- 批准号:
8147047 - 财政年份:2011
- 资助金额:
$ 11.9万 - 项目类别:
Characterization of Pathogenic T cells in Alopecia Areata
斑秃致病性 T 细胞的特征
- 批准号:
8213547 - 财政年份:2010
- 资助金额:
$ 11.9万 - 项目类别:
Characterization of Pathogenic T cells in Alopecia Areata
斑秃致病性 T 细胞的特征
- 批准号:
7880365 - 财政年份:2010
- 资助金额:
$ 11.9万 - 项目类别:
Characterization of Pathogenic T cells in Alopecia Areata
斑秃致病性 T 细胞的特征
- 批准号:
8045448 - 财政年份:2010
- 资助金额:
$ 11.9万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists